Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Director | $6.7M | May 7, 2021 | ||
AMLX | Amylyx Pharmaceuticals, Inc. | Director | $3.36M | +$220K | +7% | Jan 24, 2025 |
AUPH | Aurinia Pharmaceuticals Inc. | Director | $887K | May 18, 2023 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|